Trial · NCT04737187
Results by group112
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 112
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival (OS) | Trifluridine/Tipiracil + Bevacizumab | 10.78 | 95% Confidence Interval 9.36 to 11.83 | months | |
| Overall Survival (OS) | Trifluridine/Tipiracil | 7.46 | 95% Confidence Interval 6.34 to 8.57 | months | |
| Survival Probability at 6 Months | Trifluridine/Tipiracil + Bevacizumab | 0.77 | 95% Confidence Interval 0.72 to 0.82 | probability of participants | |
| Survival Probability at 6 Months | Trifluridine/Tipiracil | 0.61 | 95% Confidence Interval 0.55 to 0.67 | probability of participants | |
| Survival Probability at 12 Months | Trifluridine/Tipiracil + Bevacizumab | 0.43 | 95% Confidence Interval 0.36 to 0.49 | probability of participants | |
| Survival Probability at 12 Months | Trifluridine/Tipiracil | 0.30 | 95% Confidence Interval 0.24 to 0.36 | probability of participants | |
| Survival Probability at 18 Months | Trifluridine/Tipiracil + Bevacizumab | 0.28 | 95% Confidence Interval 0.19 to 0.37 | probability of participants | |
| Survival Probability at 18 Months | Trifluridine/Tipiracil | 0.15 | 95% Confidence Interval 0.09 to 0.22 | probability of participants | |
| Progression Free Survival (PFS) | Trifluridine/Tipiracil + Bevacizumab | 5.55 | 95% Confidence Interval 4.50 to 5.88 | months | |
| Progression Free Survival (PFS) | Trifluridine/Tipiracil | 2.40 | 95% Confidence Interval 2.07 to 3.22 | months | |
| Probability of Participants With Progression Free Survival at 3, 6, 9 and 12 Months | Trifluridine/Tipiracil + Bevacizumab | At 3 Months | 0.73 | 95% Confidence Interval 0.67 to 0.78 | probability of participants |
| Probability of Participants With Progression Free Survival at 3, 6, 9 and 12 Months | Trifluridine/Tipiracil | At 3 Months | 0.45 | 95% Confidence Interval 0.39 to 0.51 | probability of participants |
| Probability of Participants With Progression Free Survival at 3, 6, 9 and 12 Months | Trifluridine/Tipiracil + Bevacizumab | At 6 Months | 0.43 | 95% Confidence Interval 0.37 to 0.49 | probability of participants |
| Probability of Participants With Progression Free Survival at 3, 6, 9 and 12 Months | Trifluridine/Tipiracil | At 6 Months | 0.16 | 95% Confidence Interval 0.11 to 0.21 | probability of participants |
| Probability of Participants With Progression Free Survival at 3, 6, 9 and 12 Months | Trifluridine/Tipiracil + Bevacizumab | At 9 Months | 0.28 | 95% Confidence Interval 0.22 to 0.34 | probability of participants |
| Probability of Participants With Progression Free Survival at 3, 6, 9 and 12 Months | Trifluridine/Tipiracil | At 9 Months | 0.05 | 95% Confidence Interval 0.03 to 0.09 | probability of participants |
| Probability of Participants With Progression Free Survival at 3, 6, 9 and 12 Months | Trifluridine/Tipiracil + Bevacizumab | At 12 Months | 0.16 | 95% Confidence Interval 0.12 to 0.21 | probability of participants |
| Probability of Participants With Progression Free Survival at 3, 6, 9 and 12 Months | Trifluridine/Tipiracil | At 12 Months | 0.01 | 95% Confidence Interval 0.00 to 0.03 | probability of participants |
| Overall Response Rate (ORR) | Trifluridine/Tipiracil + Bevacizumab | 6.10 | 95% Confidence Interval 3.45 to 9.86 | percentage of participants | |
| Overall Response Rate (ORR) | Trifluridine/Tipiracil | 1.22 | 95% Confidence Interval 0.25 to 3.52 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04737187/results